Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Stock Analysis & Winston Score
Park Ha Biological Technology is a small China-based company that develops and sells personal care and health products. Its offerings include skincare items, health supplements, and related consumer goods. The company operates in the household and personal products industry, targeting everyday consumers primarily in the Chinese market. Park Ha generates revenue by selling its products through retail and online channels. It is a micro-cap company with very limited scale compared to major personal care brands. While its gross margins are high, the company currently spends far more than it earns, with deeply negative operating margins and returns on capital. The key risk for investors is whether Park Ha can grow sales fast enough to cover its operating costs and reach profitability, especially given intense competition in China's crowded consumer products market.
Winston Score: 37/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (10/30)
- Growth: Good (10/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $2.70
Market Cap: $2M
Sector: Consumer Defensive
Industry: Household & Personal Products
Exchange: NASDAQ Global Market
